Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gotlib

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|June 25, 1989
Multiple (alpha-NH-ubiquitin)protein endoproteases in cellsS Jonnalagadda, T R Butt, B P Monia, et al.
Molecular Pharmacology|August 1, 1987
Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be relatedR G Shorr, M D Minnich, A Varrichio, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsJ H Condra, E A Emini, L Gotlib, et al.
The Journal of Biological Chemistry|February 5, 1990
Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cellsJ H Condra, V V Sardana, J E Tomassini, et al.
The Journal of Biological Chemistry|January 5, 1993
Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequenceS S Carroll, D B Olsen, C D Bennett, et al.
The Journal of Biological Chemistry|September 5, 1992
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitorsV V Sardana, E A Emini, L Gotlib, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitroM G Cordingley, R L LaFemina, P L Callahan, et al.
Biochemistry|March 1, 1994
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding siteV V Sardana, A J Schlabach, P Graham, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1994
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitorsV W Byrnes, E A Emini, W A Schleif, et al.
Intensive Care Medicine|December 11, 2014
Is there a role for physician involvement in introducing research to surrogate decision makers in the intensive care unit? (The Approach trial: a pilot mixed methods study)K E A Burns, L Rizvi, O M Smith, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|June 25, 1989
Multiple (alpha-NH-ubiquitin)protein endoproteases in cellsS Jonnalagadda, T R Butt, B P Monia, et al.
Molecular Pharmacology|August 1, 1987
Immuno cross-reactivity suggests that catecholamine biosynthesis enzymes and beta-adrenergic receptors may be relatedR G Shorr, M D Minnich, A Varrichio, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1992
Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsJ H Condra, E A Emini, L Gotlib, et al.
The Journal of Biological Chemistry|February 5, 1990
Bacterial expression of antibody fragments that block human rhinovirus infection of cultured cellsJ H Condra, V V Sardana, J E Tomassini, et al.
The Journal of Biological Chemistry|January 5, 1993
Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequenceS S Carroll, D B Olsen, C D Bennett, et al.
The Journal of Biological Chemistry|September 5, 1992
Functional analysis of HIV-1 reverse transcriptase amino acids involved in resistance to multiple nonnucleoside inhibitorsV V Sardana, E A Emini, L Gotlib, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitroM G Cordingley, R L LaFemina, P L Callahan, et al.
Biochemistry|March 1, 1994
Human immunodeficiency virus type 1 protease inhibitors: evaluation of resistance engendered by amino acid substitutions in the enzyme's substrate binding siteV V Sardana, A J Schlabach, P Graham, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1994
Susceptibilities of human immunodeficiency virus type 1 enzyme and viral variants expressing multiple resistance-engendering amino acid substitutions to reserve transcriptase inhibitorsV W Byrnes, E A Emini, W A Schleif, et al.
Intensive Care Medicine|December 11, 2014
Is there a role for physician involvement in introducing research to surrogate decision makers in the intensive care unit? (The Approach trial: a pilot mixed methods study)K E A Burns, L Rizvi, O M Smith, et al.
Pageof 3